Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cortexyme, Inc. | EVP, Preclinical Development | Common Stock | 148K | $139K | $0.94 | Jun 6, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QNCX | Cortexyme, Inc. | Jun 6, 2022 | 1 | -$31.2K | 4 | Jun 8, 2022 | EVP, Preclinical Development |
QNCX | Cortexyme, Inc. | Mar 3, 2022 | 1 | $0 | 4 | Mar 4, 2022 | EVP, Preclinical Development |
QNCX | Cortexyme, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | EVP, R&D |